Concurrent Weekly Cisplatin and Simultaneous Integrated Boost Intensity-Modulated Radiotherapy of Locally Advanced Squamous Cell Carcinoma of Head and Neck

This is the dataset of 40 patients with locally advanced squamous cell carcinoma of the head and neck in stage III and IVA (TNM 7th Ed.) prospectively treated with simultaneous integrated boost intensity-modulated radiotherapy with concurrent weekly cisplatin at the Department of Radiation Oncology of the East Slovakia Institute of Oncology. Long-term treatment outcomes, acute and late toxicity were evaluated.